The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of Parkinson??s disease
- 1 December 1998
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pharmacogenetics
- Vol. 8 (6), 473???480
- https://doi.org/10.1097/00008571-199812000-00003